All seven of 23andMe’s independent board members resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the company private. Wojcicki, who has been trying to take the ...
DNA test sales have dropped off ... Once valued at $3.5 billion, 23andMe’s market cap now hovers below $200 million. Nonetheless, the drug development and genetic sequencing that the firm ...